Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Pramlintide

APP

AstraZeneca · Not applicable · Recruiting · Enrollment 18

NCT07506369

ArmPopulationDoseWeeksEstimandWeight change
Amylin (Pramlintide) + PlaceboObesity or overweightn/rn/rn/rn/r
PP + PlaceboObesity or overweightn/rn/rn/rn/r
Amylin (Pramlintide) + PPObesity or overweightn/rn/rn/rn/r
Placebo + PlaceboObesity or overweightn/rn/rn/rn/r